AI Summary

Researchers at the University of California, Riverside have made a breakthrough in treating fragile X syndrome in mice. The study involved a gene therapy designed to replace a missing brain protein, which is associated with the condition. The results showed that this therapy restored normal brain activity and improved behavior in the mice. The findings suggest that gene therapy could potentially be used to address the underlying causes of fragile X syndrome, although further research is needed to confirm this.

AI summaries can be wrong sometimes—always verify important details using the source article.